
MVKAGRO
NSEPrice History
Investment Checklist
Technical Analysis
Technical Analysis
Analysis from 2026-06-12
Trend
Price below most MAs — downtrend
Price Action
Support & Resistance Levels
Volume Analysis
Stop Loss Levels
Fixed Risk
Technical Levels
Financials
Peer Comparison
SugarPeer Comparison
| Symbol | Name | Price | Change |
|---|---|---|---|
| BALRAMCHIN | Balrampur Chini Mills Limited | ₹539.95 | -1.57% |
| TRIVENI | Triveni Engineering & Industries Limited | ₹385.95 | +0.88% |
| RENUKA | Shree Renuka Sugars Limited | ₹22.29 | +2.81% |
| BANARISUG | Bannari Amman Sugars Limited | ₹3,615.60 | +0.32% |
| DALMIASUG | Dalmia Bharat Sugar and Industries Limited | ₹327.65 | +1.25% |
| BAJAJHIND | Bajaj Hindusthan Sugar Limited | ₹18.94 | +2.32% |
| DHAMPURSUG | Dhampur Sugar Mills Limited | ₹141.27 | -1.33% |
| AVADHSUGAR | Avadh Sugar & Energy Limited | ₹452.20 | -0.52% |
| UTTAMSUGAR | Uttam Sugar Mills Limited | ₹230.88 | -0.14% |
| DWARKESH | Dwarikesh Sugar Industries Limited | ₹44.28 | -1.73% |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 20 Sept 2024 | ANNUAL GENERAL MEETING | AGM |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for MVKAGRO
View AllAlembic Pharmaceuticals receives USFDA approval for Tretinoin Cream USP, 0.05%
Alembic Pharmaceuticals (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Tretinoin Cream USP, 0.05%. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Retin-A Cream, 0.05%, of Bausch Health US, LLC. Tretinoin cream is indicated for topical application in the treatment of acne vulgaris.
How Gen Z became the most important customer in FMCG
Young consumers are now driving major decisions at established food companies. Gen-Z and millennials are influencing product development, acquisitions, and marketing strategies. These younger shoppers are health-conscious, digitally savvy, and demand transparency. Their preferences are reshaping the entire packaged foods industry in India.
Alembic Pharmaceuticals receives USFDA tentative approval for Larotrectinib Capsules
Alembic Pharmaceuticals has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Larotrectinib Capsules, 25 mg and 100 mg. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Vitrakvi Capsules, 25 mg and 100 mg, of Bayer Healthcare Pharmaceuticals Inc. (Bayer).